The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The ...

To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but also ...

Blood tests help doctors detect multiple myeloma by measuring changes in blood cells and proteins associated with bone marrow cancer. A complete blood count (CBC) can show low red blood cells or ...